Sharp Therapeutics Stock Price, News & Analysis
SHRXF
Company Description
Welcome to the overview page for Sharp Therapeutics (SHRXF), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$0.0
Market Cap
30.0M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Sharp Therapeutics.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
January 1, 2026 - December 31, 2026
Phase I clinical trial
Planned Phase I trials for Gaucher and Progranulin programs